drugset / Trial / NCT01760421

The Effect of Hydroxychloroquine Treatment in Hashimoto's Thyroiditis

NCT01760421

Completed 40 enrolled National Taiwan University Hospital
NaSingle-groupOpen-labelTreatment

Summary

Hashimoto's thyroiditis is an autoimmune thyroid disease, which induced chronic inflammation of thyroid gland and destroys thyroid tissue. Hydroxychloroquine is used as disease modifying anti-rheumatic drug (DMARD) for treatment of several autoimmune diseases, such as systemic lupus erythematosus (SLE), rheumatoid arthritis(RA) for more than one century. The purpose of this study is to evaluate whether hydroxychloroquine is effective in treatment of Hashimoto's thyroiditis.

Timeline

Start
2011-10
Primary completion
2012-12
Completion
2013-08

Drugs

EvaluationDrugModalityDoseRoute
Subject Hydroxychloroquine Small molecule 200 mg Oral

Indications